United Therapeutics Corporation - UTHR

UTHR Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
UTHR	-2.0	-1.1	-5.5	-3.7	8.3	61.5	69.3	285.4	145.0	5790.1
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare UTHR with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	UTHR
name	United Therapeutics Corporation
price	358.93
changes percentage	-2.04
change	-7.46
day low	357.25
day high	372.34
year high	417.82
year low	208.62
market cap	16024250385
price avg 50	370.44
price avg 200	326.05
exchange	NASDAQ
volume	237736
avg volume	320457
open	372.34
previous close	366.39
eps	22.75
pe	15.78
earnings announcement	2025-02-19T13:30:00.000+0000
shares outstanding	44644500
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 80.3%

Overall Quarterly Financial Health: 79.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001082554
revenue	2327500000	1936300000	20.20
gross profit	2070000000	1789600000	15.67
gross profit ratio	0.89	0.92	-3.77
research and development expenses	408000000	322900000	26.35
operating expenses	885100000	809900000	9.29
interest income	162700000	45200000	259.96
interest expense	59300000	32400000	83.02
ebitda	1386800000	1040300000	33.31
ebitdaratio	0.6	0.51	17.16
operating income	1184900000	979700000	20.95
operating income ratio	0.51	0.51	0.62
net income	984800000	727300000	35.40
net income ratio	0.42	0.38	12.65
eps	21.04	15.98	31.66

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,328 million in 2023 from 1,936 million in 2022 representing a change of 20.2%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,070 million in 2023 from 1,790 million in 2022 representing a change of 15.67%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 408 million in 2023 from 323 million in 2022 representing a change of 26.35%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,387 million in 2023 from 1,040 million in 2022 representing a change of 33.31%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 985 million in 2023 from 727 million in 2022 representing a change of 35.4%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 21.04 in 2023 from 21.04 in 2022 representing a change of 31.66%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 885 million in 2023 from 810 million in 2022 representing a change of 9.29%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 1,185 million in 2023 from 980 million in 2022 representing a change of 20.95%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001082554
revenue	748900000	714900000	4.76
gross profit	665800000	637100000	4.50
gross profit ratio	0.89	0.89	-0.24
research and development expenses	103500000	139600000	-25.86
operating expenses	322700000	317200000	1.73
interest income	49800000	46200000	7.79
interest expense	10100000	11600000	-12.93
ebitda	417800000	338600000	23.39
ebitdaratio	0.56	0.47	17.79
operating income	343100000	319900000	7.25
operating income ratio	0.46	0.45	2.38
net income	309100000	278100000	11.15
net income ratio	0.41	0.39	6.10
eps	6.93	6.26	10.70

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 749 million in 2024Q3 from 715 million in 2024Q2 representing a change of 4.76%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 666 million in 2024Q3 from 637 million in 2024Q2 representing a change of 4.5%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 418 million in 2024Q3 from 339 million in 2024Q2 representing a change of 23.39%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 343 million in 2024Q3 from 320 million in 2024Q2 representing a change of 7.25%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 309 million in 2024Q3 from 278 million in 2024Q2 representing a change of 11.15%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 6.93 in 2024Q3 from 6.93 in 2024Q2 representing a change of 10.7%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 104 million in 2024Q3 from 140 million in 2024Q2 representing a change of -25.86%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 323 million in 2024Q3 from 317 million in 2024Q2 representing a change of 1.73%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001082554
total assets	7167000000	6044500000	18.57
total liabilities	1182200000	1247800000	-5.26
total equity	5984800000	4796700000	24.77
cash and cash equivalents	1207700000	961200000	25.65
short term investments	1786400000	1877500000	-4.85
long term investments	1909800000	1316200000	45.10
total current assets	3551000000	3380300000	5.05
total non current assets	3616000000	2664200000	35.73
total current liabilities	804400000	343200000	134.38
total non current liabilities	377800000	904600000	-58.24
common stock	700000	700000	0.00
retained earnings	6027100000	5042300000	19.53
total debt	700000000	800000000	-12.50

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 7,167 million in 2023 from 6,044 million in 2022 representing a change of 18.57%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 1,182 million in 2023 from 1,248 million in 2022 representing a change of -5.26%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 5,985 million in 2023 from 4,797 million in 2022 representing a change of 24.77%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,208 million in 2023 from 961 million in 2022 representing a change of 25.65%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 3,551 million in 2023 from 3,380 million in 2022 representing a change of 5.05%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 6,027 million in 2023 from 5,042 million in 2022 representing a change of 19.53%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 700 million in 2023 from 800 million in 2022 representing a change of -12.5%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 1,786 million in 2023 from 1,878 million in 2022 representing a change of -4.85%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 804 million in 2023 from 343 million in 2022 representing a change of 134.38%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001082554
total assets	7123100000	6723200000	5.95
total liabilities	1022200000	1026000000	-0.37
total equity	6100900000	5697200000	7.09
cash and cash equivalents	1553900000	1355700000	14.62
short term investments	1772600000	1615800000	9.70
long term investments	1279400000	1359400000	-5.88
total current assets	4000400000	3619500000	10.52
total non current assets	3122700000	3103700000	0.61
total current liabilities	873400000	832300000	4.94
total non current liabilities	148800000	193700000	-23.18
common stock	700000	700000	0.00
retained earnings	6920900000	6611800000	4.67
total debt	400000000	500000000	-20.00

Overall Score of Quarterly Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 7,123 million in 2024Q3 from 6,723 million in 2024Q2 representing a change of 5.95%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 1,022 million in 2024Q3 from 1,026 million in 2024Q2 representing a change of -0.37%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 6,101 million in 2024Q3 from 5,697 million in 2024Q2 representing a change of 7.09%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,554 million in 2024Q3 from 1,356 million in 2024Q2 representing a change of 14.62%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 1,773 million in 2024Q3 from 1,616 million in 2024Q2 representing a change of 9.7%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 4,000 million in 2024Q3 from 3,620 million in 2024Q2 representing a change of 10.52%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 6,921 million in 2024Q3 from 6,612 million in 2024Q2 representing a change of 4.67%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 400 million in 2024Q3 from 500 million in 2024Q2 representing a change of -20.0%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Liabilities: Total Current Liabilities increased to 873 million in 2024Q3 from 832 million in 2024Q2 representing a change of 4.94%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001082554
net change in cash	246500000	66400000	271.23
operating cash flow	978000000	802500000	21.87
free cash flow	747600000	663700000	12.64
capital expenditure	-230400000	-138800000	-65.99
depreciation and amortization	53200000	51300000	3.70
deferred income tax	0	-71700000	100.00
stock based compensation	39100000	106800000	-63.39
accounts payables	57100000	150600000	-62.08
inventory	-13600000	-13400000	-1.49
acquisitions net	-89200000	7100000	-1,356.34
investments in property plant and equipment	-230400000	-138800000	-65.99
net cash used for investing activites	-719600000	-811500000	11.32
debt repayment	-100000000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-13800000	-11400000	-21.05
dividends paid	0	0	NaN
net cash used provided by financing activities	-11900000	75400000	-115.78
cash at end of period	1207700000	961200000	25.65
accounts receivables	-58500000	-21700000	-169.59
cash at beginning of period	961200000	894800000	7.42

Overall Score of Annual Cashflow Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 246 million in 2023 from 66 million in 2022 representing a change of 271.23%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 978 million in 2023 from 802 million in 2022 representing a change of 21.87%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 748 million in 2023 from 664 million in 2022 representing a change of 12.64%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -230 million in 2023 from -139 million in 2022 representing a change of -65.99%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 39 million in 2023 from 107 million in 2022 representing a change of -63.39%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 57 million in 2023 from 151 million in 2022 representing a change of -62.08%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -58 million in 2023 from -22 million in 2022 representing a change of -169.59%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -72 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001082554
operating cash flow	377200000	232200000	62.45
free cash flow	300700000	187100000	60.72
capital expenditure	-76500000	-45100000	-69.62
depreciation and amortization	19100000	18700000	2.14
deferred income tax	0	-3500000	100.00
stock based compensation	41700000	49700000	-16.10
accounts receivables	-51100000	16500000	-409.70
accounts payables	33000000	25800000	27.91
inventory	-11300000	-14700000	23.13
acquisitions net	0	0	NaN
investments in property plant and equipment	-76500000	-45100000	-69.62
net cash used for investing activites	-114900000	-80000000	-43.62
debt repayment	-100000000	-100000000	0.00
common stock issued	0	0	NaN
common stock repurchased	-400000	-11500000	96.52
dividends paid	0	0	NaN
net cash used provided by financing activities	-64100000	-48000000	-33.54
net change in cash	198200000	104200000	90.21
cash at end of period	1553900000	1355700000	14.62
cash at beginning of period	1355700000	1251500000	8.33

Overall Score of Quarterly Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 198 million in 2024Q3 from 104 million in 2024Q2 representing a change of 90.21%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 377 million in 2024Q3 from 232 million in 2024Q2 representing a change of 62.45%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 301 million in 2024Q3 from 187 million in 2024Q2 representing a change of 60.72%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -76 million in 2024Q3 from -45 million in 2024Q2 representing a change of -69.62%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 42 million in 2024Q3 from 50 million in 2024Q2 representing a change of -16.1%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -51 million in 2024Q3 from 16 million in 2024Q2 representing a change of -409.7%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q3 from -4 million in 2024Q2 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 33 million in 2024Q3 from 26 million in 2024Q2 representing a change of 27.91%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	49.73	42.56	16.86
net income per share	21.04	15.98	31.64
operating cash flow per share	20.9	17.64	18.48
free cash flow per share	15.97	14.59	9.51
cash per share	63.98	62.39	2.54
book value per share	127.88	105.42	21.30
tangible book value per share	125.44	104.44	20.10
shareholders equity per share	127.88	105.42	21.30
interest debt per share	16.22	18.29	-11.32
market cap	10290852000	12653095000.0	-18.67
enterprise value	9783152000	12491895000.0	-21.68
pe ratio	10.45	17.4	-39.94
price to sales ratio	4.42	6.53	-32.34
pocfratio	10.52	15.77	-33.26
pfcf ratio	13.77	19.06	-27.80
pb ratio	1.72	2.64	-34.82
ptb ratio	1.72	2.64	-34.82
ev to sales	4.2	6.45	-34.85
enterprise value over ebitda	7.05	12.01	-41.25
ev to operating cash flow	10.0	15.57	-35.74
ev to free cash flow	13.09	18.82	-30.47
earnings yield	0.1	0.06	66.49
free cash flow yield	0.07	0.05	38.50
debt to equity	0.12	0.17	-29.87
debt to assets	0.1	0.13	-26.20
net debt to ebitda	-0.37	-0.15	-136.26
current ratio	4.41	9.85	-55.18
interest coverage	19.98	30.24	-33.92
income quality	0.99	1.1	-10.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.17	0.21	-20.99
research and ddevelopement to revenue	0.18	0.17	5.12
intangibles to total assets	0.02	0.01	116.44
capex to operating cash flow	0.24	0.17	36.21
capex to revenue	0.1	0.07	38.09
capex to depreciation	4.33	2.71	60.07
stock based compensation to revenue	0.02	0.06	-69.54
graham number	246.06	194.72	26.37
roic	0.14	0.13	2.99
return on tangible assets	0.14	0.12	15.19
graham net net	44.38	39.72	11.74
working capital	2746600000	3037100000	-9.57
tangible asset value	5870600000	4752200000	23.53
net current asset value	2368800000	2132500000	11.08
invested capital	3906200000	3943100000	-0.94
average receivables	249650000	209550000	19.14
average payables	4849999.5	3949999.5	22.78
average inventory	106900000	97900000	9.19
days sales outstanding	43.74	41.55	5.27
days payables outstanding	7.94	10.2	-22.19
days of inventory on hand	158.47	253.78	-37.56
receivables turnover	8.35	8.79	-5.01
payables turnover	45.98	35.78	28.51
inventory turnover	2.3	1.44	60.14
roe	0.16	0.15	8.52
capex per share	4.92	3.05	61.38

• Positive

  ROE: Return on Equity (ROE) increased to 0.16 on 2023-12-31 from 0.15 on 2022-12-31, representing a change of 8.52%. Suggesting the company has been generating high returns for its shareholders.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.12 on 2023-12-31 from 0.17 on 2022-12-31, representing a change of -29.87%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 10.45 on 2023-12-31 from 17.40 on 2022-12-31, representing a change of -39.94%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 4.41 on 2023-12-31 from 9.85 on 2022-12-31, representing a change of -55.18%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
UTHR
calendar year	2024	2024	NaN
revenue per share	16.79	16.1	4.29
net income per share	6.93	6.26	10.65
operating cash flow per share	8.46	5.23	61.72
free cash flow per share	6.74	4.21	60.00
cash per share	74.59	66.93	11.44
book value per share	136.79	128.32	6.61
tangible book value per share	134.28	125.72	6.81
shareholders equity per share	136.79	128.32	6.61
interest debt per share	9.2	11.52	-20.20
market cap	15982410000.0	14164044000	12.84
enterprise value	14828510000.0	13308344000	11.42
pe ratio	12.93	12.73	1.52
price to sales ratio	21.34	19.81	7.72
pocfratio	42.37	61.0	-30.54
pfcf ratio	53.15	75.7	-29.79
pb ratio	2.62	2.49	5.37
ptb ratio	2.62	2.49	5.37
ev to sales	19.8	18.62	6.36
enterprise value over ebitda	35.49	39.3	-9.70
ev to operating cash flow	39.31	57.31	-31.41
ev to free cash flow	49.31	71.13	-30.67
earnings yield	0.02	0.02	-1.50
free cash flow yield	0.02	0.01	42.43
debt to equity	0.07	0.09	-25.29
debt to assets	0.06	0.07	-24.49
net debt to ebitda	-2.76	-2.53	-9.29
current ratio	4.58	4.35	5.32
interest coverage	33.97	27.58	23.18
income quality	1.22	0.83	46.15
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.27	0.21	24.50
research and ddevelopement to revenue	0.14	0.2	-29.23
intangibles to total assets	0.02	0.02	-8.15
capex to operating cash flow	0.2	0.19	4.42
capex to revenue	0.1	0.06	61.92
capex to depreciation	4.01	2.41	66.07
stock based compensation to revenue	0.06	0.07	-19.91
graham number	146.05	134.47	8.61
roic	0.04	0.04	3.11
return on tangible assets	0.04	0.04	4.76
graham net net	59.06	50.27	17.49
working capital	3127000000	2787200000	12.19
tangible asset value	5988800000	5582000000	7.29
net current asset value	2978200000	2593500000	14.83
invested capital	4395800000	3997000000	9.98
average receivables	316250000	299000000	5.77
average payables	344600000	315200000	9.33
average inventory	141600000	128350000	10.32
days sales outstanding	41.08	36.6	12.24
days payables outstanding	394.12	376.31	4.73
days of inventory on hand	158.88	157.9	0.62
receivables turnover	2.19	2.46	-10.91
payables turnover	0.23	0.24	-4.52
inventory turnover	0.57	0.57	-0.61
roe	0.05	0.05	3.79
capex per share	1.72	1.02	68.86

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.05 on 2024-06-30 Q2, representing a change of 3.79%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 4.58 on 2024-09-30 Q3 from 4.35 on 2024-06-30 Q2, representing a change of 5.32%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 12.93 on 2024-09-30 Q3 from 12.73 on 2024-06-30 Q2, representing a change of 1.52%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.07 on 2024-09-30 Q3 from 0.09 on 2024-06-30 Q2, representing a change of -25.29%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 378.28 which is higher than current price 358.93, indicates the company may be undervalued.